Drug Access Spike
by Medegen Medical Manufacturing Services
510(k) K051930
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK051930 | Date16 Aug 2005 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- FMF
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5860
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
A Drug Access Spike is a device designed for accessing medication from a vial or container, typically used in conjunction with a syringe to facilitate drug transfer or reconstitution. It is classified under the product code FMF and regulation 880.5860 as a Syringe, Piston type device intended for general hospital use.
The device was submitted as a traditional 510(k) by Medegen Medical Manufacturing Services and received FDA clearance on August 16, 2005, under K051930, with a decision of substantially equivalent (SESE). It is supplied as a non-sterile, single-use device and is intended for use in general hospital settings, with no claims of MRI safety or reusability indicated in the provided data.
Other devices from Medegen Medical Manufacturing Services, Inc.
Questions
AI-generated answers, 21 Sep 2026
What is the Drug Access Spike used for?
The Drug Access Spike is designed to access medication from a vial or container, facilitating drug transfer or reconstitution when used with a syringe in general hospital settings.
Is the Drug Access Spike sterile or non-sterile, and is it intended for single use or reuse?
The device is supplied as non-sterile and is intended for single-use only, with no indication of reusability in the provided data.
What regulatory pathway was used for the Drug Access Spike, and when was it cleared?
The Drug Access Spike was submitted as a traditional 510(k) and received FDA clearance on August 16, 2005, under K051930, with a decision of substantially equivalent.